Your browser doesn't support javascript.
loading
Real-World Assessment of Interferon-ß-1b and Interferon-ß-1a Adherence Before and After the Introduction of the BETACONNECT® Autoinjector: A Retrospective Cohort Study.
Butler, Oisín; Heeg, Simone; Holl, Katsiaryna; Frenz, Ann-Kathrin; Wicklein, Eva-Maria; Rametta, Mark; Yeo, Sandy.
Afiliação
  • Butler O; Medical Affairs and Pharmacovigilance, Pharmaceuticals, RWE Strategy & Outcomes Data Generation, Bayer AG, Building P300, 13342, Berlin, Germany. oisin.butler@bayer.com.
  • Heeg S; Medical Affairs and Pharmacovigilance, Pharmaceuticals, RWE Strategy & Outcomes Data Generation, Bayer AG, Building P300, 13342, Berlin, Germany.
  • Holl K; Medical Affairs and Pharmacovigilance, Pharmaceuticals, RWE Strategy & Outcomes Data Generation, Bayer AG, Building P300, 13342, Berlin, Germany.
  • Frenz AK; Research and Development, Bayer AG, Berlin, Germany.
  • Wicklein EM; Medical Affairs and Pharmacovigilance, Pharmaceuticals, RWE Strategy & Outcomes Data Generation, Bayer AG, Building P300, 13342, Berlin, Germany.
  • Rametta M; US Medical Affairs, Specialty Medicine and Pipeline Products, Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, USA.
  • Yeo S; Bayer (South East Asia) Pte Ltd, Singapore, Singapore.
Drugs Real World Outcomes ; 8(3): 359-367, 2021 Sep.
Article em En | MEDLINE | ID: mdl-33928518

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies Idioma: En Revista: Drugs Real World Outcomes Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies Idioma: En Revista: Drugs Real World Outcomes Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha